BMC Medical Showcases Global Innovations in Respiratory Health at Major Conferences

BMC Medical, a leading name in respiratory and sleep health solutions, showcased its increasing global presence and commitment to digital health at two major events in May: the ARTP Annual Conference in Glasgow and HOSPITALAR 2025 in São Paulo.

Participation at ARTP Annual Conference

During the ARTP Annual Conference held on May 1st and 2nd, BMC connected with respiratory health professionals from the UK and Europe to explore how technology is reshaping the management of chronic respiratory diseases. A significant focus was placed on telemonitoring solutions enabling real-time data exchange and remote patient engagement, which are essential for improving adherence and treatment outcomes for Positive Airway Pressure (PAP) therapy. BMC presented its PAP Link digital health solution as an effective tool for personalizing treatment and enhancing continuity of care beyond clinical settings.

Highlights from HOSPITALAR 2025

Later in May, BMC made a notable presence at HOSPITALAR 2025, Latin America's leading medical trade show, which took place from May 20th to 23rd. At this event, BMC showcased a comprehensive range of respiratory innovations including the M1 Mini series, the G3 BPAP series, HFNC devices, RV series ventilators, and the digital health solution PAP Link. This exhibition underscored the company’s dedication to making sleep and respiratory care more innovative and accessible worldwide.

Commitment to Innovation and Accessibility

BMC Medical's participation in these two significant conferences highlights its ongoing commitment to enhancing sleep and respiratory care through innovation. As the landscape of healthcare continues to evolve, BMC remains poised to lead the future of respiratory care with intelligent and accessible solutions for patients globally, specifically where healthcare is most needed.

BMC Medical Co., Ltd. focuses exclusively on improving respiratory health through innovative and accessible technologies that connect hospitals and homes. With a presence in over 100 countries, BMC empowers healthcare professionals and patients to confidently manage sleep and respiratory disorders.

Conclusion

BMC Medical is dedicated to being at the forefront of respiratory health innovation. By actively participating in renowned events such as ARTP and HOSPITALAR 2025, the company affirms its leadership in the respiratory health landscape and its commitment to developing technologies that support healthcare professionals and improve patient outcomes. As BMC continues to invest in research and development, the impact of its solutions is likely to expand, further transforming the respiratory care environment across the globe. BMC is more than just a company; it is a partner in health, dedicated to enhancing lives through cutting-edge solutions in respiratory care.